Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors

Regulatory Peptides

Volumn 90, Issue 1-3, 2000, Pages 19-25

  Dimmeler, Stefanie ^a   Zeiher, Andreas M ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Caspases; Cell death; Endothelial cells; Kinases; Smooth muscle cells

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANGIOTENSIN; ANTIOXIDANT; ASCORBIC ACID; CASPASE; GLUTATHIONE; PEROXYNITRITE; PHOSPHOTRANSFERASE; PROTEIN BCL 2; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; HUMAN; MITOCHONDRIAL MEMBRANE; NONHUMAN; PREVENTION; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; REACTIVE OXYGEN SPECIES;

EID: 0034733776     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(00)00105-1     Document Type: Review

References (60)

1. White E. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1996;1-15.
2. MacLellan W.R., Schneider M.D. Death by design: programmed cell death in cardiovascular biology and disease. Circ Res. 81:1997;137-144.
3. Dimmeler S., Hermann C., Zeiher A.M. Apoptosis of endothelial cells - contribution to the pathophysiology of atherosclerosis. Eur Cytokine Netw. 9:1998;697-698.
4. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 57:1995;791-804.
5. Caplan B.A., Schwartz C.J. Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta. Atherosclerosis. 17:1973;401-417.
6. Bennett M.R. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res. 41:1999;361-368.
7. Kockx M.M., De Meyer G.R., Muhring J., Jacob W., Bult H., Herman A.G. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 97:1998;2307-2315.
8. Jacobson M.D. Reactive oxygen species and programmed cell death. TIBS. 21:1996;83-86.
9. Haimovitz-Friedman A., Cordon-Cardo C., Bayoumy S., Garzotto M., McLoughlin M., Gallily R., Edwards C.Kr., Schuchman E.H., Fuks Z., Kolesnick R. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med. 186:1997;1831-1841.
10. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:1993;2546-2551.
11. Alexander R.W. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension. 25:1995;155-161.
12. Dimmeler S., Hermann C., Galle J., Zeiher A.M. Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol. 19:1999;656-664.
13. 2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase. Arterioscler Thromb Vasc Biol. 17:1997;3588-3592.
14. Dimmeler S., Haendeler J., Galle J., Zeiher A.M. Oxidized low density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: a mechanistic clue to the response to injury hypothesis. Circulation. 95:1997;1760-1763.
15. Galle J., Schneider R., Heinloth A., Wanner C., Galle P.R., Conzelmann E., Dimmeler S., Heermeier K. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress. Kidney Int. 55:1999;1450-1461.
16. Warnholtz A., Nickenig G., Schulz E., Macharzina R., Brasen J.H., Skatchkov M., Heitzer T., Stasch J.P., Griendling K.K., Harrison D.G., Bohm M., Meinertz T., Munzel T. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation. 99:1999;2027-2033.
17. Dimmeler S., Rippmann V., Weiland U., Haendeler J., Zeiher A.M. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res. 81:1997;970-976.
18. Walter D.H., Haendeler J., Galle J., Zeiher A.M., Dimmeler S. Cyclosporine A inhibits apoptosis of human endothelial cells by preventing the release of cytochrome c from mitochondria. Circulation. 98:1998;1153-1157.
19. Abello P.A., Fidler S.A., Bulkley G.B., Buchman T.G. Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin. Arch Surg. 129:1994;134-140. discussion 140-141.
20. Haendeler J., Zeiher A.M., Dimmeler S. Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur J Pharmacol. 317:1996;407-411.
21. Li A.E., Ito H., Rovira I.I., Kim K.S., Takeda K., Yu Z.Y., Ferrans V.J., Finkel T. A role for reactive oxygen species in endothelial cell anoikis. Circ Res. 85:1999;304-310.
22. Shimokawa H., Aarhus L.L., Vanhoutte P.M. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res. 61:1987;256-270.
23. Dimmeler S., Haendeler J., Nehls M., Zeiher A.M. Suppression of apoptosis by nitric oxide via inhibition of ICE-like and CPP32-like proteases. J Exp Med. 185:1997;601-608.
24. Sata M., Walsh K. Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP. J Biol Chem. 273:1998;33103-33106.
25. Scaffidi C., Schmitz I., Zha J., Korsmeyer S.J., Krammer P.H., Peter M.E. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem. 274:1999;22532-22538.
26. Reed J.C. Cytochrome c: cant live with it - cant live without it. Cell. 91:1997;559-562.
27. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
28. Lorenzo H.K., Susin S.A., Penninger J., Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ. 6:1999;516-524.
29. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.-I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
30. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
31. Guarente L. Mutant mice live longer. Nature 1999;402:243, 245.
32. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., Hoffman B., Reed J.C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1994;1799-1805.
33. Dimmeler S., Breitschopf K., Haendeler J., Zeiher A.M. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med. 189:1999;1815-1822.
34. Hermann C., Rössig L., Zeiher A.M., Dimmeler S. Angiotensin II-induced apoptosis of human endothelial cells is mediated by up-regulation of MAP-kinase phosphatase-3. Circulation. 100:(Suppl):1999;325.
35. Breitschopf K, Haendeler J, Malchow P, Zeiher AM. Posttranscriptional modification of Bcl-2: molecular characterization of the involved signaling pathways. Mol Cell Biol (in press).
36. Horiuchi M., Hayashida W., Kambe T., Yamada T., Dzau V.J. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phophatase-1 and induces apoptosis. J Biol Chem. 272:1997;19022-19026.
37. Costantini P., Belzacq A.S., Vieira H.L., Larochette N., de Pablo M.A., Zamzami N., Susin S.A., Brenner C., Kroemer G. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces bcl-2-independent permeability transition pore opening and apoptosis [In Process Citation]. Oncogene. 19:2000;307-314.
38. Harada-Shiba M., Kinoshita M., Kamido H., Shimokado K. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J Biol Chem. 273:1998;9681-9687.
39. Yao B., Zhang Y., Delikat S., Mathias S., Basu S., Kolesnick R. Phosphorylation of Raf by ceramide-activated protein kinase. Nature. 378:1995;307-310.
40. Basu S., Kolesnick R. Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene. 17:1998;3277-3285.
41. Dimmeler S., Zeiher A.M. Nitric oxide - an endothelial cell survival factor. Cell Death Differ. 6:1999;964-968.
42. Pryor W.A., Squadrito G.L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide and superoxide. Am J Physiol. 268:1995;L699-L722.
43. Inoue N., Ramasamy S., Fukai T., Nerem R.M., Harrison D.G. Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ Res. 79:1996;32-37.
44. Li P.F., Dietz R., von Harsdorf R. Reactive oxygen species induce apoptosis of vascular smooth muscle cell. FEBS Lett. 404:1997;249-252.
45. Li P.F., Dietz R., von Harsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation. 96:1997;3602-3609.
46. Fiorani M., Cantoni O., Tasinato A., Boscoboinik D., Azzi A. Hydrogen peroxide- and fetal bovine serum-induced DNA synthesis in vascular smooth muscle cells: positive and negative regulation by protein kinase C isoforms. Biochim Biophys Acta. 1269:1995;98-104.
47. Johnson T.M., Yu Z.X., Ferrans V.J., Lowenstein R.A., Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci USA. 93:1996;11848-11852.
48. Griendling K.K., Harrison D.G. Dual role of reactive oxygen species in vascular growth [editorial; comment]. Circ Res. 85:1999;562-563.
49. Rao G.N., Berk B.C. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res. 70:1992;593-599.
50. Tsai J.C., Jain M., Hsieh C.M., Lee W.S., Yoshizumi M., Patterson C., Perrella M.A., Cooke C., Wang H., Haber E., Schlegel R., Lee M.E. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J Biol Chem. 271:1996;3667-3670.
51. Brown M.R., Miller F.J. Jr., Li W.G., Ellingson A.N., Mozena J.D., Chatterjee P., Engelhardt J.F., Zwacka R.M., Oberley L.W., Fang X., Spector A.A., Weintraub N.L. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells [see comments]. Circ Res. 85:1999;524-533.
52. 2 for platelet-derived growth factor signal transduction. Science. 270:1995;296-299.
53. Ushio-Fukai M., Alexander R.W., Akers M., Yin Q., Fujio Y., Walsh K., Griendling K.K. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem. 274:1999;22699-226704.
54. 2 in angiotensin II-induced vascular hypertrophy. Hypertension. 32:1998;488-495.
55. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 74:1994;1141-1148.
56. Marumo T., Schini-Kerth V.B., Fisslthaler B., Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation. 96:1997;2361-2367.
57. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol. 10:1998;248-253.
58. Pollman M.J., Yamada T., Horiuchi M., Gibbons G.H. Vasoactive substances regulate vascular smooth muscle cell apoptosis - countervailing influences of nitric oxide and angiotensin II. Circ Res. 79:1996;748-756.
59. 2- in vascular smooth muscle cells. Circ Res. 77:1995;29-36.
60. Touyz R.M., Deng L.Y., He G., Wu X.H., Schiffrin E.L. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. J Hypertens. 17:1999;907-916.